Mike Dybbs
InvestorUnicorn founderDirector & Co-founder at Kalaris Therapeutics, Inc. · Partner at Samsara BioCapital
Burlingame, California
Writes $10M – $100M checks · typically $25M
Find your path to Mike
770 people in our graph share verified history with Mike — schools, employers, funds. One of them is your warm intro.
Adam ValkinunlockedMike: together at Harvard University (1993–1996)
×7Mike: together at University of California, Berkeley
×4Mike: together at Harvard University
Contact· self-published, not guessed
Experience
- Samsara BioCapitalPartnercurrent2017 — present
- Dimension TherapeuticsBoard of Directors2015 — 2017
- Principia BiopharmaBoard of Directors2014 — 2016
- Advanced Cell DiagnosticsBoard of Directors2012 — 2016
- New Leaf Venture PartnersPartner2009 — 2016
- Versartis, Inc.Board of Directors2013 — 2014
- The Boston Consulting GroupPrincipal2005 — 2009
Investments
Investor
Advanced Cell DiagnosticsArcellxClaris BiotherapeuticsDimension TherapeuticsIonPathNkarta TherapeuticsPrincipia BiopharmaRayze BioSutrobioVersartis
Per curated public sources.
Colleagues at Samsara BioCapital
Abe Bassan
Principal at Samsara BioCapital
Cory Freedland
Investor at Samsara BioCapital
Marcos Milla
Venture Partner at Samsara BioCapital
Robert Baffi
Venture Partner at Samsara BioCapital
Srini Akkaraju
Founder and Managing Partner at Samsara BioCapital
Srinivas Akkaraju
General Partner at Samsara BioCapital
Frequently asked questions
- Who is Mike Dybbs?
- Partner at Samsara BioCapital
- Where does Mike Dybbs work?
- Mike Dybbs is Director & Co-founder of Kalaris Therapeutics, Inc. and Partner at Samsara BioCapital.
- What check size does Mike Dybbs write?
- Mike Dybbs typically writes checks of $10M – $100M.
- What companies did Mike Dybbs found?
- Mike Dybbs founded Kalaris Therapeutics, Inc..
- What companies has Mike Dybbs invested in?
- Investments tracked here include Advanced Cell Diagnostics, Arcellx, Claris Biotherapeutics, Dimension Therapeutics, IonPath, Nkarta Therapeutics, Principia Biopharma, Rayze Bio, Sutrobio, Versartis.
- Where did Mike Dybbs go to school?
- Mike Dybbs studied at University of California, Berkeley (PhD, Molecular and Cellular Biology); Harvard University (AB, Biochemical Sciences).
Same school
Also attended University of California, Berkeley2,000
Steve WozniakCo-founder of AppleAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksAbraham BachrachCo-founder & CTO of SkydioTrevor OelschigInvestment Team at General CatalystAnthony LinHead of Intel Capital, Corporate Vice President at Intel Capital
+ 1,994 more
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Shared employers
Also worked at Dimension Therapeutics2
Also worked at Principia Biopharma6
Chris ChaiOperating Partner - Portfolio Capital Raising at SR One Capital ManagementPeter ThompsonGeneral Partner at OrbiMedPeter Thompson, M.D.Investor at OrbiMedRichard A. MillerPresident & CEO, Co-Founder at CorvuspharmaMartin BablerPresident, Chief Executive Officer and Chairman of the Board at AlumisClaire LangrishSVP, Head of Immunology and Translational Science at Alumis
Also worked at New Leaf Venture Partners11
Ron HuntManaging Director at New Leaf Venture PartnersCraig SlutzkinCOO / CFO at New Leaf Venture PartnersSrini AkkarajuFounder and Managing Partner at Samsara BioCapitalDoug Fisher, MDPartner at Revelation PartnersEliot CharlesPartner at Apax DigitalAsha NayakInvestor at Johnson & Johnson Innovation – JJDC
+ 5 more
Also worked at The Boston Consulting Group1,460
Cristina JunqueiraCo-founder of NubankMassimo PrelzInvestor at DN CapitalRasmus AreskougInvestor at DN CapitalRiccardo MontiOperating Advisor at P101 VenturesAntonio TurroniOperating Advisor at P101 VenturesLuca RossettoOperating Advisor at P101 Ventures
+ 1,454 more




































